Biotech startups in New South Wales, Australia
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Cauldron Ferm | Orange | Series A | $13.2M | 2026-03-24 |
| Omniscient Neurotechnology | Sydney | Series D | $13.4M | 2026-01-16 |
| HealthMatch | Surry Hills | Series C | $6.9M | 2022-09-12 |
| Levur | Sydney | Pre-seed | $780K | 2025-05-06 |
| RoseRx | Sydney | Seed | $4.9M | 2025-06-07 |
5 rows of the CSV in 5 of its 18 columns.
- The 31 biotech startups in New South Wales, Australia have raised $619.4M in total.
- 5 of them closed their most recent round in the last 12 months, $344.8M combined.
- The largest of those rounds is AdvanCell's $315.0M Series D, dated July 2026.
- The most recent is Eudaemon Technologies' $3.1M seed round on 13 October 2026.
- Main Sequence Ventures is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 26 companies (84%).
- 27% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 1 to 10 employees (59% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
3 of 31| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Cauldron Ferm | Cauldron Ferm scales precision fermentation prototypes up to commercial quantities through a bio-acceleration process. | Biotech | Orange | Series A | $13.2M | 2026-03-24 | $32.1M | SOSV, IQT, Horizons Ventures +1 | 11 to 50 | 2023 |
| Omniscient Neurotechnology | Omniscient Neurotechnology develops AI and data solutions with predictive analytics to improve brain disorder treatment. | Artificial intelligence | Sydney | Series D | $13.4M | 2026-01-16 | $57.2M | Base Capital | 51 to 100 | 2019 |
| HealthMatch | HealthMatch connects patients with new drugs and treatments. | Artificial intelligence | Surry Hills | Series C | $6.9M | 2022-09-12 | $27.5M | Square Peg Capital, January Capital, Folklore Ventures +1 | 11 to 50 | 2017 |
Table 1. Biotech startups in New South Wales, Australia: the 3 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 31.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Omniscient Neurotechnology | Omniscient Neurotechnology develops AI and data solutions with predictive analytics to improve brain disorder treatment. | Artificial intelligence | Sydney | Series D | $13.4M | 2026-01-16 | $57.2M | Base Capital | 51 to 100 | 2019 |
| 2 | Cauldron Ferm | Cauldron Ferm scales precision fermentation prototypes up to commercial quantities through a bio-acceleration process. | Biotech | Orange | Series A | $13.2M | 2026-03-24 | $32.1M | SOSV, IQT, Horizons Ventures +1 | 11 to 50 | 2023 |
Table 2. Biotech startups in New South Wales, Australia: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Main Sequence Ventures | Venture capital firm | Sydney, Australia | 2 | 6% | 1 | Cauldron Ferm |
| 2 | Australian Medical Angels | Angel group | Sydney, Australia | 2 | 6% | ||
| 3 | SOSV | Venture capital firm | Princeton, United States | 1 | 3% | 1 | Cauldron Ferm |
| 4 | IQT | Startup accelerator | Arlington, United States | 1 | 3% | 1 | Cauldron Ferm |
| 5 | Horizons Ventures | Venture capital firm | Hong Kong | 1 | 3% | 1 | Cauldron Ferm |
| 6 | Base Capital | Venture capital firm | Cape Town, South Africa | 1 | 3% | 1 | Omniscient Neurotechnology |
| 7 | Athletic Ventures | Syndicate | Sydney, Australia | 1 | 3% | ||
| 8 | Folklore Ventures | Venture capital firm | Sydney, Australia | 1 | 3% | ||
| 9 | January Capital | Venture capital firm | Singapore | 1 | 3% | ||
| 10 | Square Peg Capital | Venture capital firm | Surry Hills, Australia | 1 | 3% | ||
| 11 | SparkLabs Cultiv8 | Startup accelerator | Orange, Australia | 1 | 3% | ||
| 12 | SpringCapital Investment | Venture capital firm | Sydney, Australia | 1 | 3% | ||
| 13 | Artesian VC | Venture capital firm | Melbourne, Australia | 1 | 3% | ||
| 14 | Vulpes Investment Management Pte Ltd | Hedge fund | Singapore | 1 | 3% | ||
| 15 | Breyer Capital | Venture capital firm | Menlo Park, United States | 1 | 3% |
Table 3. Biotech startups in New South Wales, Australia: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 26 | 84% | $587.2M |
| Software | 7 | 23% | $84.7M |
| Artificial intelligence | 5 | 16% | $84.7M |
Table 4. Biotech startups in New South Wales, Australia by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 2 | 6% | $780K |
| Seed | 20 | 65% | $2.8M |
| Series A | 4 | 13% | $16.8M |
| Series B | 2 | 6% | $77.1M |
| Series C | 1 | 3% | $6.9M |
| Series D+ | 2 | 6% | $315.0M |
Table 5. Biotech startups in New South Wales, Australia by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Sydney | 20 | 65% |
| Orange | 2 | 6% |
| Darlinghurst | 2 | 6% |
| Neutral Bay | 1 | 3% |
| Surry Hills | 1 | 3% |
| Leichhardt | 1 | 3% |
| Kogarah | 1 | 3% |
| City Of Sydney | 1 | 3% |
| Manly Vale | 1 | 3% |
| Castle Hill | 1 | 3% |
Table 6. Biotech startups in New South Wales, Australia by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 20% | $3.1M |
| July 2026 | 1 | 20% | $315.0M |
| April 2026 | 1 | 20% | |
| March 2026 | 1 | 20% | $13.2M |
| January 2026 | 1 | 20% | $13.4M |
Table 7. Biotech startups in New South Wales, Australia: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 5 | 16% | $344.8M |
| 2025 | 2 | 6% | $5.7M |
| 2024 | 1 | 3% | $16.8M |
| 2023 | 5 | 16% | $77.1M |
| 2022 | 5 | 16% | $32.7M |
| 2021 | 1 | 3% | $7K |
Table 8. Biotech startups in New South Wales, Australia by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 4 | 13% |
| 2020 to 2022 | 4 | 13% |
| 2015 to 2019 | 16 | 53% |
| 2010 to 2014 | 3 | 10% |
| Before 2010 | 3 | 10% |
Table 9. Biotech startups in New South Wales, Australia by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 17 | 59% |
| 11 to 50 | 7 | 24% |
| 51 to 100 | 3 | 10% |
| 101 to 250 | 2 | 7% |
Table 10. Biotech startups in New South Wales, Australia by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in New South Wales, Australia. On 16 November 2026 that is 31 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 3 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 31 rows: 15 have no round amount, 0 no city and 17 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in New South Wales, Australia are on the list?
- 31, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 31 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.